Clinical Trial Update: Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of floxuridine, dexamethasone, and irinotecan after surgery in patients with liver metastases from colorectal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Floxuridine (floxuridine)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colorectal Cancer, Metastatic Cancer | Phase 2 | Status: COMPLETED